ZLN-005
A novel small molecule PGC-1α transcriptional activator; increases expression of the PGC-1α gene and downstream genes by activation of AMP-activated protein kinase, and improves glucose uptake and fatty acid oxidation without obvious cytotoxicity in L6 myotubes; produces antihyperglycemia and antihyperlipidemia effects and increases insulin sensitivity in db/db mice.Diabetes Preclinical.
Product Specifications
CAS Number
49671-76-3
Product Name Alternative
ZLN 005 | ZLN005
Purity
>98% (HPLC)
Solubility
DMSO: ≥ 47 mg/mL
Smiles
CC (C1=CC=C (C2=NC3=CC=CC=C3N2) C=C1) (C) C
Molecular Formula
C17H18N2
Molecular Weight
250.3382
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1H-Benzimidazole, 2-[4- (1,1-dimethylethyl) phenyl]-
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog